Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...

From a virus's point of view, invading our cells is a matter of survival. The virus makes a living by highjacking cellular processes to produce more of the proteins that make it up. From our point of ...

The last time I wrote about Abeona Therapeutics (ABEO) it was in a Seeking Alpha article entitled "Abeona: BLA Resubmission of Pz-Cel Gets Ball Rolling Towards Other Milestones." With respect to this ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure Accurate viral vector characterization in ...

Agreement grants Lilly rights to employ Sangamo’s novel proprietary capsid, STAC-BBB, for up to five potential disease targets Sangamo to receive an $18 million upfront license fee and is eligible to ...

A joint research team discovered and characterized ushikuvirus, a new giant DNA virus that infects vermamoeba. This image (a) ...